If at eight weeks your skin remains significantly worse than baseline with no improvement trend, something isn't working
Xylo Research Systems LLC, dba Panda Peptides, is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act
TB500 has zero published human trials
Published trials show up to 70% increases in collagen output in vitro and significant improvements in skin density in 12-week human clinical studies
Studies show it affects over 4,000 human genes, with 70% of changes promoting tissue healing and regeneration (Campbell et al., BioMed Research International, 2012)
Each peptide has its own dosing, reconstitution, and stability considerations